Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 7, 1999
Issued Date -
N/A
app pub date -
Apr 30, 1998
filing date -
May 15, 1995
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Inflammatory bowel disease, especially Crohn's disease and ulcerative colitis, is treated by administration of an oral dosage form, containing as an active principle an omega-3 polyunsaturated acid in free acid form or as a pharmaceutically acceptable salt thereof, which releases the acid in the ileum. Preferably the oral dosage form is a gelatine capsule coated with a poly(ethylacrylate-methylmethacrylate).
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully